- Warren Hosseinion, President and director at Nutex Health, reported acquiring 252 shares of common stock at USD 94.07 per share.
- Following the reported transaction, he beneficially owned 7,765 shares of common stock.
- The filing also reported 12,465 restricted stock units beneficially owned following the reported transaction.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nutex Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001438327-26-000002), on March 23, 2026, and is solely responsible for the information contained therein.
Comments